The Department of Defense, through the Defense Logistics Agency (DLA) Troop Support, is seeking vendors to provide Hemostatic Gauze, Chitosan-Based, for Military Treatment Facilities (MTFs) within the Military Health System (MHS). The objective of this procurement is to standardize medical materiel and achieve competitive pricing for an estimated annual demand of approximately $364,456.74, with the selected vendor expected to support an 80% purchase velocity of the standardized product line. Interested vendors must be on the Qualified Suppliers List (QSL) and submit their pricing offers, along with required documentation, by November 21, 2024, to the designated Points of Contact, Arthur Redmond and David Sheaffer, via email. The anticipated selection date for the Incentive Agreement is December 17, 2024, and the agreement will last for five years.